KEBERHASILAN PROGRAM EMAS DALAM MENINGKATKAN PEMBERIAN MGSO4 PRARUJUKAN OLEH BIDAN
KASUS RUJUKAN KE RSUD SERANG 2012-2013
Abstract
Berdasarkan laporan program EMAS 2011, stabilisasi MgSO4 prarujukan di 6 propinsi di Indonesia masih rendah. Penelitian deskriptif dengan design cross-sectional ini bertujuan untuk melihat keberhasilan pendekatan sistem, program EMAS dalam penguatan peran bidan terkait pemberian stabilisasi MgSO4 prarujukan di puskesmas yang merujuk ke RSUD Serang. Penelitian dilakukan di RSUD Serang terhadap semua kasus rujukan PEB dan Eklampsia dari puskesmas tahun 2012-2013, sebanyak 822 kasus. Hasil penelitian menunjukkan, bahwa program EMAS yang dimulai pada bulan Maret 2012 di kabupaten Serang, berhasil meningkatkan presentasi pemberian MgSO4, pada puskesmas intervensi EMAS, persentase pemberian MgSO4 prarujukan bulan Januari-Maret 2012 masih rendah berkisar antara 25% - 53%, dan persentasenya meningkat signifikan di mei sebesar 88% sampai bulan desember sebesar 94%. Tahun 2013, persentasenya selalu berkisar antara ≥ 90% setiap bulannya bahkan mencapai 100%. Penguatan sistem rujukan melalui kebijakan termasuk dukungan spesialis dan sistem SMS gateway di RSUD Serang juga berhasil meningkatkan pemberian MgSO4 prarujukan di puskesmas non intervensi EMAS. Mei 2012 persentasenya mulai meningkat sebesar 64% sampai bulan desember 2012 mencapai 84%. Tahun 2013, persentasenya terus meningkat sampai di bulan desember sebesar 93%, namun di bulan juli turun sampai 47%, karena sulit mengontrol kualitas di tingkat puskesmas non intervensi EMAS
References
2. Expanding Maternal and Neonatal Survival. 2012. Annual Report For Expanding Maternal and Neonatal Survival, Jakarta: USAID
3. Carl H. Backes. et al. 2011 Maternal Preeclampsia and Neonatal Outcomes, Journal of Pregnancy ; April 2011: 214365.
4. Kementerian Kesehatan.2013. Buku Saku Pelayanan Kesehatan Ibu di Fasilitas Kesehatan Dasar dan Rujukan, Jakarta:Kemenkes
5. Altman D. et al. 2002. “Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial”. Lancet, 359 (9321):1877-1890
6. Kementerian Kesehatan. 2014. Analisis Situasi Kesehatan Neonatal, Jakarta:Kemenkes
Please find the rights and licenses in Jurnal Ilmiah Bidan (JIB). By submitting the article/manuscript of the article, the author(s) agree with this policy. No specific document sign-off is required.
1. License
The non-commercial use of the article will be governed by the Creative Commons Attribution license as currently displayed on Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
2. Author(s)' Warranties
The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).
3. User/Public Rights
JIB's spirit is to disseminate articles published are as free as possible. Under the Creative Commons license, JIB permits users to copy, distribute, display, and perform the work for non-commercial purposes only. Users will also need to attribute authors and JIB on distributing works in the journal and other media of publications. Unless otherwise stated, the authors are public entities as soon as their articles got published.
4. Rights of Authors
Authors retain all their rights to the published works, such as (but not limited to) the following rights;
- Copyright and other proprietary rights relating to the article, such as patent rights,
- The right to use the substance of the article in own future works, including lectures and books,
- The right to reproduce the article for own purposes,
- The right to self-archive the article (please read out deposit policy),
- The right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the article's published version (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal (Jurnal Ilmiah Bidan).
5. Co-Authorship
If the article was jointly prepared by more than one author, any authors submitting the manuscript warrants that he/she has been authorized by all co-authors to be agreed on this copyright and license notice (agreement) on their behalf, and agrees to inform his/her co-authors of the terms of this policy. JIB will not be held liable for anything that may arise due to the author(s) internal dispute. JIB will only communicate with the corresponding author.
6. Royalties
Being an open accessed journal and disseminating articles for free under the Creative Commons license term mentioned, author(s) aware that JIB entitles the author(s) to no royalties or other fees.
7. Miscellaneous
JIB will publish the article (or have it published) in the journal if the article’s editorial process is successfully completed. JIB's editors may modify the article to a style of punctuation, spelling, capitalization, referencing and usage that deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers as mentioned in point 3.
